The content of EZH2 was found to be elevated in breast cancer SCs in comparison with normal tissue-specific SCs, suggesting that EZH2 may initiate cancer growth by blocking the differentiation of somatic SCs [38,40]. This evidence concerns the gene EZH2 and breast cancer.